Mast AE - Search Results

1

Profiling constitutive proteolytic events in vivo.

Timmer JC, Enoksson M, Wildfang E, Zhu W, Igarashi Y, Denault JB, Ma Y, Dummitt B, Chang YH, Mast AE, Eroshkin A, Smith JW, Tao WA, Salvesen GS. Timmer JC, et al. Among authors: mast ae. Biochem J. 2007 Oct 1;407(1):41-8. doi: 10.1042/BJ20070775. Biochem J. 2007. PMID: 17650073 Free PMC article.

2

Conformation of the reactive site loop of alpha 1-proteinase inhibitor probed by limited proteolysis.

Mast AE, Enghild JJ, Salvesen G. Mast AE, et al. Biochemistry. 1992 Mar 17;31(10):2720-8. doi: 10.1021/bi00125a012. Biochemistry. 1992. PMID: 1547212

3

Analysis of the plasma elimination kinetics and conformational stabilities of native, proteinase-complexed, and reactive site cleaved serpins: comparison of alpha 1-proteinase inhibitor, alpha 1-antichymotrypsin, antithrombin III, alpha 2-antiplasmin, angiotensinogen, and ovalbumin.

Mast AE, Enghild JJ, Pizzo SV, Salvesen G. Mast AE, et al. Biochemistry. 1991 Feb 12;30(6):1723-30. doi: 10.1021/bi00220a039. Biochemistry. 1991. PMID: 1704258

4

Kinetics and physiologic relevance of the inactivation of alpha 1-proteinase inhibitor, alpha 1-antichymotrypsin, and antithrombin III by matrix metalloproteinases-1 (tissue collagenase), -2 (72-kDa gelatinase/type IV collagenase), and -3 (stromelysin).

Mast AE, Enghild JJ, Nagase H, Suzuki K, Pizzo SV, Salvesen G. Mast AE, et al. J Biol Chem. 1991 Aug 25;266(24):15810-6. J Biol Chem. 1991. PMID: 1651920 Free article.

5

Polyethylene glycol modification of serpins improves therapeutic potential.

Mast AE, Salvesen G, Brucato FH, Schnebli HP, Pizzo SV. Mast AE, et al. Biol Chem Hoppe Seyler. 1990 May;371 Suppl:101-9. Biol Chem Hoppe Seyler. 1990. PMID: 2400571 No abstract available.

6

In vivo catabolism of alpha 1-antichymotrypsin is mediated by the Serpin receptor which binds alpha 1-proteinase inhibitor, antithrombin III and heparin cofactor II.

Pizzo SV, Mast AE, Feldman SR, Salvesen G. Pizzo SV, et al. Among authors: mast ae. Biochim Biophys Acta. 1988 Nov 17;967(2):158-62. doi: 10.1016/0304-4165(88)90005-0. Biochim Biophys Acta. 1988. PMID: 3263884

7

Evaluation of the rapid plasma elimination of recombinant alpha 1-proteinase inhibitor: synthesis of polyethylene glycol conjugates with improved therapeutic potential.

Mast AE, Salvesen G, Schnebli HP, Pizzo SV. Mast AE, et al. J Lab Clin Med. 1990 Jul;116(1):58-65. J Lab Clin Med. 1990. PMID: 2376698

8

Caveolae optimize tissue factor-Factor VIIa inhibitory activity of cell-surface-associated tissue factor pathway inhibitor.

Maroney SA, Ellery PE, Wood JP, Ferrel JP, Bonesho CE, Mast AE. Maroney SA, et al. Among authors: mast ae. Biochem J. 2012 Apr 1;443(1):259-66. doi: 10.1042/BJ20111994. Biochem J. 2012. PMID: 22239091 Free PMC article.

9

Structural and functional characterization of tissue factor pathway inhibitor following degradation by matrix metalloproteinase-8.

Cunningham AC, Hasty KA, Enghild JJ, Mast AE. Cunningham AC, et al. Among authors: mast ae. Biochem J. 2002 Oct 15;367(Pt 2):451-8. doi: 10.1042/BJ20020696. Biochem J. 2002. PMID: 12117418 Free PMC article.

10

Proteolytic inactivation of alpha-1-anti-chymotrypsin. Sites of cleavage and generation of chemotactic activity.

Potempa J, Fedak D, Dubin A, Mast A, Travis J. Potempa J, et al. J Biol Chem. 1991 Nov 15;266(32):21482-7. J Biol Chem. 1991. PMID: 1793458 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

157 results

Search Page